International Journal of Research in Pharmacy and Allied Science

ISSN: 2583-6544   |  Issues per year: Monthly  |   Indexed In: Google Scholar, CORE, ScienceOpen, Researchgate

ISSN:2583-6544

Abstract View

A Narrative Review of the Prevalence, Types, and Contributing Factors of Drug-Related Problems in Hospitals.

Author(s): Tanvi Madane*1, Dr. Rohini Chavan2

Email(s): 1tanvimadane2002@gmail.com

Address:

    Department of Pharmacy Practice, PES’s Modern College of Pharmacy, Nigdi, Pune-411044, India.

Published In:   Volume - 5,      Issue - 3,     Year - 2026

DOI: https://doi.org/10.71431/IJRPAS.2026.5303  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Medication is one of the most commonly used treatments used in modern healthcare; its use is frequently linked to drug-related problems, such as medication errors, adverse drug reactions, and inappropriate prescribing. Because concurrent conditions, clinical complications, and poly pharmacy are common in hospital settings, these issues can have a substantial impact on treatment outcomes and the safety of patients. To categorize the most widely used DRPs in clinical settings, determine which drug classes are most commonly associated, and emphasize risk factors and successful interventions, a systematic review was carried out. PubMed, Scopus, Google Scholar, Web of Science, and the Cochrane Library were used to conduct a thorough literature search for research published between 2018 and 2025.Data on study characteristics, DRP types and prevalence, risk factor, and interventions were extracted from relevant articles on medication errors, adverse drug events, and drug-related hospital admissions. The most common DRPs, according to the review findings, were Drug choice problem (Inappropriate drug selection, untreated indications), Dosing problem (incorrect dose selection), adverse drug events, and drug-drug interactions. The main groups of drugs involved were antimicrobial, cardiovascular agents, antidiabetic drugs, and drugs that affect the central nervous system. Polypharmacy, advanced age, several comorbidities, extended hospitalization, and clinical complexity were all contributing factors. Finally, DRPs continue to be a prevalent and avoidable issue in patient care. Improving prescribing procedures, encouraging interdisciplinary cooperation, and fortifying clinical pharmacy services are all crucial to lowering DRPs, boosting patient safety, and enhancing therapeutic results.

Keywords:

Cite this article:
Tanvi Madane, Dr. Rohini Chavan. A Narrative Review of the Prevalence, Types, and Contributing Factors of Drug-Related Problems in Hospitals. IJRPAS, March 2026; 5(3): 25-43.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2026.5303


1. Baron S, Linton S, O'Malley MA. Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine. 2023;48(6):551-564.

2. Elliott RA, Camacho E, Jankovic D, Sculpher MJ, Faria R. Economic analysis of the prevalence and clinical and economic burden of medication error in England. BMJ Qual Saf. 2021;30(2):96-105.

3. Rémi C, Bauer D, Krumm L, Bausewein C. Drug-related problems on a palliative care unit. J Pain Palliat Care Pharmacother. 2021;35(4):264-272.

4. Kempen TG, Hedman AN, Hadziosmanovic N, Lindner KJ, Melhus H, Nielsen EI, Sulku J, Gillespie U. Risk factors for and preventability of drug-related hospital revisits in older patients: a post-hoc analysis of a randomized clinical trial. Br J Clin Pharmacol. 2023;89(5):1575-1587.

5. Ayalew MB, Tegegn HG, Abdela OA. Drug-related hospital admissions: a systematic review of the recent literature. Bull Emerg Trauma. 2019;7(4):339.

6. Bekele F, Bereda G, Tamirat L, Geleta BA, Jabessa D. Children are not just “little adults”: the rate of medication-related problems and its predictors among patients admitted to a pediatric ward of a southwestern Ethiopian hospital: a prospective observational study. Ann Med Surg (Lond). 2021;70:102827.

7. Alshammari FM, Alanazi EJ, Alanazi AM, Alturifi AK, Alshammari TM. Medication error concept and reporting practices in Saudi Arabia: a multiregional study among healthcare professionals. Risk Manag Healthc Policy. 2021;14:2395-2406.

8. Rababa’h AM, Mardini AN, Ababneh MA, Rababa M, Hayajneh M. Medication errors in Jordan: a systematic review. Int J Crit Illn Inj Sci. 2022;12(2):106-114.

9. Lim R, Ellett LM, Semple S, Roughead EE. The extent of medication-related hospital admissions in Australia: a review from 1988 to 2021. Drug Saf. 2022;45(3):249-257.

10. Hamadouk RM, Mohammed FM, Albashair ED, Yousef BA. Evaluation of community pharmacists’ competences in identifying and resolving drug-related problems in a pediatric prescription using the simulated patient method. Pharmacy (Basel). 2023;11(1):6.

11. Nguyen TH, Le VT, Quach DN, Diep HG, Nguyen NK, Lam AN, Pham ST, Taxis K, Nguyen T, Nguyen PM. Drug-related problems in prescribing for pediatric outpatients in Vietnam. Healthcare (Basel). 2021;9(3):327.

12. Pramotesiri P, Putthipokin K, Ruangritchankul S. Drug-related problems among older inpatients at a tertiary care setting. J Clin Med. 2024;13(6):1638.

13. Elhabil MK, Yousif MA, Ahmed KO, Abunada MI, Almghari KI, Eldalo AS. Impact of clinical pharmacist-led interventions on drug-related problems among pediatric cardiology patients: first Palestinian experience. Integr Pharm Res Pract. 2022;11:127-137.

14. Bekele F, Fekadu G, Bekele K, Dugassa D, Sori J. Drug-related problems among patients with infectious disease admitted to medical wards of Wollega University Referral Hospital: a prospective observational study. SAGE Open Med. 2021;9:2050312121989625.

15. Juneja D, Mishra A. Medication prescription errors in intensive care unit: an avoidable menace. Indian J Crit Care Med. 2022;26(5):541.

16. Ude-Okeleke RC, Aslanpour Z, Dhillon S, Umaru N. Medicines-related problems originating in primary care settings in older adults: a systematic review. J Pharm Pract. 2023;36(2):357-369.

17. Alshaikhmubarak FQ, Keers RN, Lewis PJ. Potential risk factors of drug-related problems in hospital-based mental health units: a systematic review. Drug Saf. 2023;46(1):19-37.

18. Zirpe KG, Seta B, Gholap S, Aurangabadi K, Gurav SK, Deshmukh AM, Wankhede P, Suryawanshi P, Vasanth S, Kurian M, Philip E. Incidence of medication error in a critical care unit of a tertiary care hospital. Indian J Crit Care Med. 2020;24(9):799.

19. Chowdhury K, Hazra A, Ghosh S, Choudhury S. Drug use survey to identify significant drug–drug interactions and assess clinical importance in an outpatient setting of a tertiary care hospital. Indian J Pharmacol. 2024;56(3):172-177.

20. Linkens AE, Milosevic V, van der Kuy PHM, Damen-Hendriks VH, Mestres-Gonzalvo C, Hurkens KP. Medication-related hospital admissions and readmissions in older patients: an overview of the literature. Int J Clin Pharm. 2020;42(5):1243-1251.

21. Naik YU, Muraraiah S, Lokesha RK. An observational study to determine the category and causes of drug-related problems among geriatric inpatients. Natl J Physiol Pharm Pharmacol. 2024;14(7):1408-1413.

22. Elliott RA, Camacho E, Campbell F, Jankovic D, Martyn-St James M, Kaltenthaler E, Wong R, Sculpher M, Faria R. Prevalence and economic burden of medication errors in the NHS in England: a rapid evidence synthesis. BMJ Qual Saf. 2021;30(2):96-105.

23. AbuRuz S, Jaber D, Basheti I, Sadeq A, Arafat M, AlAhmad M, Said A. Impact of pharmacist interventions on drug-related problems in general surgery patients: a randomized controlled trial. Eur J Hosp Pharm. 2021;28(Suppl 1):e72-e78.

24. Al-Maqbali JS, Taqi A, Al-Ajmi S, Al-Hamadani B, Al-Hamadani F, Bahram F, Al-Balushi K, Gamal S, Al-Lawati E, Al Siyabi B, Al Siyabi E. Impact of clinical pharmacists’ interventions on clinical significance and cost avoidance in a tertiary care university hospital in Oman. Pharmacy (Basel). 2022;10(5):127.

25. Awoke M, Melaku T, Beshir M. Drug-related problems and their determinants among hospitalized neonates with sepsis at Jimma University Medical Center, Ethiopia. J Pharm Health Care Sci. 2021;7:20.

26. Paul T, Palatty PL, Adnan M, George T, Rao S, Baliga MS. Audit of drug–drug interactions and adverse drug reactions due to polypharmacy in older cancer patients. Indian J Cancer. 2020;57(4):405-410.

27. Raikar SR, Sneha S, Sreeraj G, Janarthanan R, Rajkumar J. Awareness and knowledge of adverse drug reactions and pharmacovigilance among medical and nursing students and staff. Cureus. 2024;16(9).

28. Samanta S, Bhat WH, George J, Ramaiah B. Drug-related problems among type 2 diabetes mellitus patients with hypertension: a prospective observational study. Int J Basic Clin Pharmacol. 2025;14(2):213-218.

29. Mandumpala JJ, Manoj A, Baby N, Mathai SE, Antony S, Tom AA. Drug-related problems among inpatients of a general medicine department of a tertiary care hospital in South India. Asian J Pharm Res Health Care. 2023;15(1):22-28.

30. Kumar MV, Pasha MM, Varshith G, Pravalika B, Shameela M. Drug-related problems identified by a clinical pharmacist in a tertiary care hospital in South India. Indian J Pharm Pract. 2022;15(3).

31. Ahmed NA, Fouad EA, El-Asheer OM, Ghanem AS. Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit. Front Pharmacol. 2024;15:1391657.

32. Albayrak A, Başgut B, Bıkmaz GA, Karahalil B. Clinical pharmacist assessment of drug-related problems among intensive care unit patients. BMC Health Serv Res. 2022;22:79.

33. Kaur U, Chakrabarti SS, Gupta GK, Singh A, Gambhir IS. Drug-related problems in older adults in outpatient settings. Geriatr Gerontol Int. 2024;24:285-291.

34. Kuruvilla AV, Madhan R, Puttaswamy MC. Clinical pharmacist-initiated assessment of antibiotic use in surgical units. J Infect Dev Ctries. 2023;17(1):66-72.

35. Dwivedi P, Sah SK, Murthy S, Ramesh M. Identification and resolution of drug-related problems among neonates in NICU. Clin Epidemiol Glob Health. 2024;29:101728.

36. Garin N, Sole N, Lucas B, Matas L, Moras D, Rodrigo-Troyano A, Gras-Martin L, Fonts N. Drug-related problems in clinical practice. Sci Rep. 2021;11:883.

37. Endalifer BL, Ayta YD, Tsigie AW, Wondmkun YT, Kassa MT, Amare GG, Ejigu YW, Derseh MT, Ambaye AS. Drug-therapy-related problems and pharmacist interventions in a medical ward. Front Pharmacol. 2025;16:1558864.

38. Satria A, Muhammad M, Supardi S. Identification and analysis of drug-related problems incidence at hospitalized patients in Haji Regional General Hospital, Makassar. Asian J Pharm Clin Res. 2021;14(3):130-133.

39. Grace JR, et al. Assessment of adverse drug reactions occurring at the Department of Neurology of a tertiary care hospital in India. Asian J Pharm Clin Res. 2018;11(10):457-464.

40. Lekpittaya N, Kocharoen S, Angkanavisul J, Siriudompas T, Montakantikul P, Paiboonvong T. Drug-related problems identified by clinical pharmacists in an academic medical centre in Thailand. J Pharm Policy Pract. 2024;17(1):2288603.

41. Aradhya PJ, Ravi R, Chandra BJ, Ramesh M, Chalasani SH. Medication safety incidents associated with high-alert medications in intensive care. Indian J Crit Care Med. 2023;27(12):917.

42. Shirzad-Yazdi N, Taheri S, Vazin A, Shorafa E, Abootalebi SN, Hojabri K, Javanmardi F, Shafiekhani M. Drug-related problems among pediatric intensive care units. BMC Pediatr. 2024;24:714.

43. Osoro I, Amir M, Vohra M, Sharma A. Pharmacist interventions in minimizing drug-related problems in diabetes with hypertension. Int J Public Health. 2023;68:1605808.

44. Kumar M, Sahni N, Shafiq N, Yaddanapudi LN. Medication prescription errors in the intensive care unit. Indian J Crit Care Med. 2022;26(5):555.

45. Alsayed HA, Sharif-Askari FS, Sharif-Askari NS, Halwani R. Clinical pharmacist interventions in an intensive care unit reduce ICU mortality. Explor Res Clin Soc Pharm. 2024;14:100431.

46. Tharanon V, Putthipokin K, Sakthong P. Drug-related problems identified during pharmaceutical care interventions in an intensive care unit. SAGE Open Med. 2022;10:20503121221090881.

47. Liu P, Li G, Han M, Zhang C. Identification and solution of drug-related problems in the neurology unit. BMC Pharmacol Toxicol. 2021;22:1-9.

48. Bekele F, Tsegaye T, Negash E, Fekadu G. Magnitude and determinants of drug-related problems in southwestern Ethiopian hospitals. PLoS One. 2021;16(3):e0248575.

Related Images:



Recent Images



Formulation, Development & Evaluation of Drug Extended Release Tablet of Losartan Potassium Immediate Release Tablet of Valsartan
Stability-Indicating RP-HPLC Method for Determination of Empagliflozin using AQbD Approach
Retrospective Study of Rhino-Orbital Mucormycosis and its Management in a Tertiary Care Centre
Antimicrobial Potential of Allium sativum in the Era of Antibiotic Resistance: Gaps and Future Perspectives
Schiff Base: A Versatile Molecule
Dragon Fruit (Hylocereus undatus)Peel: Powerful Source of Nutrition and Health
Review of Analytical Method for Quality Assurance and Estimation of Antidiabetic drugs in Pharmaceutical Formulation
Digital Twin Framework for Modeling the Aqueous Degradation of Allicin and Its Nanocomplexes: Integrating DFT Thermodynamics, Molecular Dynamics Surrogate, and Experimental Validation
The Shifting Landscape of Female Infertility in India: A Comprehensive Review of Epidemiological Trends, Emerging Etiologies, and Clinical Interventions
Fabrication and Evaluation of Polyherbal Handwash Utilizing Tulsi (Ocimum sanctum), Bhringraj (Eclipta alba) and Harad (Terminalia chebula)

Tags


Quick Links


Latest Issues

Popular Articles